Sign Up
HB 314 Kentucky House · 2017 Regular Session

AN ACT relating to controlled substance monitoring. Amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to the Cabinet for Health and Family Services; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240 to conform.

Bill status signed all 4 stages cleared
Introduction
Feb 2017
Committee Review
Mar 2017
Senate Passage
Mar 2017
Signed into Law
Mar 2017
Introduced Feb 10, 2017 Signed Mar 27, 2017
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
25
Key actions
5
Committee
6
Amendments
1
Mar 27, 2017
Signed into law
Signed by Governor (Acts, ch. 138)
legislature
Mar 15, 2017
Legislature · Passed
Bill passed 85-9
legislature
Mar 15, 2017
Legislature · Passed
House concurred in Senate Committee Substitute, floor amendment (1) and committee amendment (1-title)
legislature
Mar 14, 2017
Legislature · Passed
Posted for passage for concurrence in Senate Committee Substitute, committee amendment (1-title) and floor amendment (1) on Wednesday, March 15, 2017
legislature
Mar 14, 2017
Committee
To Rules (H)
legislature
Mar 8, 2017
Introduced
Floor amendment (1) filed to Committee Substitute
legislature
Feb 28, 2017
Committee
To Health & Welfare (S)
legislature
Feb 22, 2017
Legislature · Passed
Posted in committee
legislature
Feb 14, 2017
Committee
To Health and Family Services (H)
legislature
Feb 10, 2017
Introduced
Introduced in House
legislature
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.